Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it

More documents

Recommendations

Info

Section Page 10. Anticoagulation for Atrial Fibrillation 1009 11. Deep Vein Thrombosis/ Pulmonary Embolism 1019 12. Coronary Artery Disease, Atherosclerosis, 1055 Prevention of Progression 13. Valvular Heart Disease 1145 14. Preliminary Reports a. Acute Myocardial Infarction 1157 b. Unstable Angina, Non-Q-Wave Myocardial Infarction 1163 c. Hypertension 1169 d. Congestive Heart Failure 1173 e. Arrhythmia 1181 f. Interventional Cardiology 1189 vi Contents
Page Acronym/Title Trials Listing Contents 1a. Acute Myocardial Infarction — Thrombolytic Therapy 2 GUSTO-III (1 Year) – Global Utilization of Streptokinase and tPA for Occluded Coronary Arteries-III 4 SPEED (GUSTO-IV Pilot) – Early Percutaneous Coronary Intervention Strategies for Patency Enhancement in the Emergency Department. Global Use of Strategies to Open Occluded Coronary Arteries IV 6 SPEED – Strategies for Patency Enhancement in the Emergency Department. Global Use of Strategies to Open Occluded Arteries (GUSTO-IV Pilot) 8 GUSTO V – Global Utilization of Strategies to Open Occluded Coronary Arteries V 11 GUSTO V – Global Utilization of Strategies to Open Occluded Coronary Arteries V 13 TIMI-4 – Thrombolysis in Myocardial Infarction-4 15 InTIME-II – Intravenous nPA for Treatment of Infarcting Myocardium Early-II 18 ASSENT (Substudy) – Assessment of the Safety and Efficacy of a New Thrombolytic Agent 20 ASSENT-2 – Assessment of the Safety and Efficacy of a New Thrombolytic-2 22 ASSENT-3 – Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 25 TUCC – Randomized Trial Confirming the Efficacy of Reduced Dose Recombinant Tissue Plasminogen Activator in a Chinese Myocardial Infarction Population and Demonstrating Superiority to Usual Dose Urokinase 27 ER-TIMI – Results of the Early Retavase-Thrombolysis In Myocardial Infarction (ER-TIMI) 19 Trial 1b. Acute Myocardial Infarction — Percutaneous Transluminal Coronary Angioplasty vs Stenting vs Thrombolytic Therapy 32 Stent-PAMI – Stent-Primary Angioplasty in Myocardial Infarction 34 Long-Term Benefit of Primary Angioplasty as Compared with Thrombolytic Therapy for Acute Myocardial Infarction Contents vii
Page 1 and 2: Cardiovascular Trials Review Eighth
Page 3 and 4: Dedicated to the memory of Philip K
Page 5: Subjects Contents Section Page 1. A
Page 9 and 10: Page Acronym/Title Contents 85 HIT-
Page 11 and 12: Page Acronym/Title Contents 176 ESC
Page 13 and 14: Page Acronym/Title Contents 260 APL
Page 15 and 16: Page Acronym/Title Contents 348 EAS
Page 17 and 18: Page Acronym/Title Contents 443 PRE
Page 19 and 20: Page Acronym/Title Contents 543 Int
Page 21 and 22: Page Acronym/Title Contents 641 CAN
Page 23 and 24: Page Acronym/Title Contents 741 COP
Page 25 and 26: Page Acronym/Title Contents 837 MIR
Page 27 and 28: Page Acronym/Title Contents 939 CTO
Page 29 and 30: Page Acronym/Title Contents 1038 PE
Page 31 and 32: Page Acronym/Title Contents 13. Val
Page 33 and 34: Introduction The purpose of Cardiov
Page 35 and 36: MIRACL Myocardial Ischemia Reductio
Page 37 and 38: ASCOT-LLA Anglo-Scandinavian Cardia
Page 39 and 40: Comparison of the Effects of Atorva
Page 41 and 42: CAPE II Trial Circadian Anti-Ischem
Page 43: CAPE II Trial Circadian Anti-Ischem

Cardiovascular Trials Review Cardiovascular Trials Review - Diegori.it

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?